NivolumabThrombotic microangiopathy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1868卷 / 1期

关键词：

D O I：

10.1007/s40278-021-00792-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：335 / 335

相关论文

共 50 条

[1] Ipilimumab/nivolumabThrombotic microangiopathy and diarrhoea: case report
[J]. Reactions Weekly, 2021, 1869 (1) : 196 - 196
[2] Bevacizumab/nivolumabThrombotic microangiopathy and hypertension: 2 case reports
[J]. Reactions Weekly, 2023, 1949 (1) : 104 - 104
[3] Bevacizumab/nivolumabThrombotic microangiopathy and acute tubulointerstitial nephritis
[J]. Reactions Weekly, 2023, 1985 (1) : 116 - 116
[4] Ipilimumab/nivolumabThrombotic thrombocytopenic purpura: case report
[J]. Reactions Weekly, 2020, 1813 (1) : 138 - 138
[5] Ipilimumab/nivolumabThrombotic thrombocytopenic purpura: case report
[J]. Reactions Weekly, 2021, 1842 (1) : 217 - 217
[6] NivolumabThrombotic thrombocytopenic purpura and microangiopathic haemolytic anaemia: case report
[J]. Reactions Weekly, 2021, 1836 (1) : 598 - 598
[7] Ipilimumab/methylprednisolone/nivolumabThrombotic thrombocytopenic purpura and lack of efficacy: case report
[J]. Reactions Weekly, 2022, 1909 (1) : 298 - 298
[8] TacrolimusThrombotic microangiopathy: case report
[J]. Reactions Weekly, 2021, 1866 (1) : 348 - 348
[9] TacrolimusThrombotic microangiopathy: case report
[J]. Reactions Weekly, 2020, 1826 (1) : 299 - 299
[10] GemcitabineThrombotic microangiopathy: case report
[J]. Reactions Weekly, 2010, 1297 (1) : 27 - 27

← 1 2 3 4 5 →